One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their ...

Study shows diabetes drugs' potential beyond weight loss A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

While we’re unlikely to see a dramatic rise in deaths from vaccine-preventable diseases in the U.S. in the near term, the ...

PFAS, also known as "forever chemicals" are found in manufacturing and consumer products and contaminate nearly half of U.S.

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

A new report noted that body mass index does not provide a nuanced enough assessment of health as it relates to weight ...